Australia markets closed

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
10.49+0.09 (+0.87%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
858,296
764,547
569,698
409,249
Cost of revenue
369,903
370,795
257,575
178,295
Gross profit
488,393
393,753
312,123
230,954
Operating expenses
Research development
88,163
67,073
68,825
50,770
Selling general and administrative
63,480
60,531
40,916
33,938
Total operating expenses
204,096
179,664
152,630
110,321
Operating income or loss
284,297
214,089
159,493
120,632
Interest expense
7,703
6,107
1,466
1,384
Income before tax
309,173
255,859
159,391
95,498
Income tax expense
25,537
20,483
13,461
8,662
Income from continuing operations
283,636
235,376
145,930
86,836
Net income
283,636
235,376
145,930
86,836
Net income available to common shareholders
283,636
235,376
145,930
86,836
Basic EPS
0.49
0.42
0.26
0.16
Diluted EPS
0.49
0.42
0.26
0.16
Basic average shares
574,851
558,519
567,506
531,871
Diluted average shares
574,851
558,519
567,506
531,871